ID   ARCaPE-shEPLIN
AC   CVCL_E7VL
SY   ARCaPE-shRNA clone #102)
RX   PubMed=21625216;
WW   Provider; Emory OTT; RT006; https://emoryott.technologypublisher.com/techcase/RT006
CC   Population: Caucasian.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:24636; LIMA1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; S.alboniger pac (PuroR).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7VJ ! ARCaPE
SX   Male
AG   83Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
RX   PubMed=21625216; DOI=10.1038/onc.2011.199; PMCID=PMC3165108;
RA   Zhang S.-M., Wang X., Osunkoya A.O., Iqbal S.A., Wang Y., Chen Z.,
RA   Muller S., Chen Z.-J., Josson S., Coleman I.M., Nelson P.S.,
RA   Wang Y.-Q.A., Wang R.-X., Shin D.M., Marshall F.F., Kucuk O.,
RA   Chung L.W.K., Zhau H.-Y.E., Wu D.-Q.;
RT   "EPLIN downregulation promotes epithelial-mesenchymal transition in
RT   prostate cancer cells and correlates with clinical lymph node
RT   metastasis.";
RL   Oncogene 30:4941-4952(2011).
//